Boston Scientific Corporation

Boston Scientific Corporation

Boston Scientific Corporation

Overview
Date Founded

1979

Headquarters

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752, USA

Type of Company

Public

Employees (Worldwide)

36K

Industries

Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Industrial Machinery & Manufacturing
Electrical Products

Company Description

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Contact Data
Trying to get in touch with decision makers at Boston Scientific Corporation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Secretary, Executive Vice President & General Counsel

Senior Vice President, General Counsel & Corporate Secretary

Senior Vice President & Chief Information Officer

Executive Vice President & Global Chief Medical Officer

Vice President, Global Controller & Chief Accounting Officer

Executive Vice President & President, Europe, Middle East & Africa

Executive Vice President & President, Peripheral Interventions

Executive Vice President & President, Asia Pacific

Paths to Boston Scientific Corporation
Potential Connections via
Relationship Science
You
Boston Scientific Corporation
Owners & Shareholders
Details Hidden

FMR may use a variety of methods of security analysis in managing client assets to select investments including fundamental analysis, quantitative analysis and cyclical analysis. They may also use general macro-economic analysis as a component of its security analysis methods. In addition to relying on public financial statement information, the firm may use extensive corporate visits and interviews with issuer management teams in conducting research. When it comes to the management of the client assets according to the investment objectives, FMR may use a variety of investment strategies including, but not limited to, investing in stocks and other public and private equity securities, bonds and other debt securities of all types and repurchase agreements for those securities, real estate related investments of all types, derivatives, currency spot and forward trading, other investment funds, including exchange traded funds and FMR's or its affiliates' central funds. They may also engage in securities lending to parties such as broker-dealers or other institutions.

Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm utilizes fundamental research to gather in-depth information on markets and companies around the world. They also employ a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Details Hidden

PRIMECAP Management aims to provide superior long-term investment results by utilizing fundamental research and bottom-up stock picking to construct portfolios. The firm looks for stocks that will outperform the market over a three to five-year horizon. PRIMECAP Management does not have a committee or small group that decides on whether or not to invest in an idea. Each portfolio manager makes an individual decision whether or not to invest in new ideas.

Recent Transactions
Details Hidden

Minerva Surgical, Inc. purchases Boston Scientific Corp. /Intrauterine Health Franchise from Boston Scientific Corporation

Details Hidden

Varian Medical Systems, Inc. purchases Boston Scientific Corp. /Drug Eluting & Bland Embolic Bus from Boston Scientific Corporation

Details Hidden

Boston Scientific Corporation purchases BTG Plc

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onBoston Scientific Corporation purchases Guidant Corporation

Accountant

Advised onBoston Scientific Corporation purchases Guidant Corporation

Legal Advisor

Advised onBoston Scientific Corporation purchases VertiFlex, Inc. from Alta Partners Management Corp., Aberdare Ventures, New Enterprise Associates, Thomas McNerney Ptn, Morgenthaler Management Corp., Endeavour Vision SA, H.I.G. BioHealth Partners LLC

Legal Advisor

Advised onBoston Scientific Corporation purchases Guidant Corporation

Legal Advisor

Advised onBoston Scientific Corporation purchases Asthmatx, Inc.

Legal Advisor

Advised onBoston Scientific Corporation purchases Symetis SA from Kreos Capital Management (UK) Ltd., Wellington Partners GmbH, Novartis Venture Fund, Aravis AG, Stage Capital Ventures, Endeavour Vision SA, Truffle Capital, BioMedPartners AG, Renaissance Management SA

Advisors & Consultants
Legal Advisor

Partner at Arnold & Porter LLP

Legal Advisor

Partner at Arnold & Porter LLP

Senior Advisor

Executive Vice President & Chief Financial Officer at Biogen, Inc.

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Beaumont Health is a non-profit organization which engages in the provision of healthcare services. It offers spine surgery, weight loss, wound treatment, home health services, integrative medicine, and senior services. The company was founded on September 2, 2014 and is headquartered in Southfield, MI.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Key Stats and Financials As of 2019
Market Capitalization
$50.5B
Total Enterprise Value
$73.6B
Earnings Per Share
$3.33
Revenue
$10.7B
Net Profit
$4.7B
EBITDAMargin
25.36%
Enterprise Value Sales
6.85x
Enterprise Value EBITDAOperating
26.9x
TEVNet Income
15.65x
Debt TEV
0.14x
EBITDA
$2.72B
Total Debt
$10.4B
Total Equity
$13.9B
Three Year Compounded Annual Growth Rate Of Revenue
8.58%
Five Year Compounded Annual Growth Rate Of Revenue
7.99%
Non-Profit Donations & Grants
Political Donations
$1,000
2014
$500
2014
$1,000
2014
Investments
Details Hidden

Amaranth Medical, Inc. develops and manufactures a technology platform for fully bioresorbable scaffolds. It operates as a holding company that engages in the development and manufacture of technology platform for fully bioresorbable scaffolds. Its proprietary bioresorbable technology platform holds great potential for both vascular and nonvascular applications. The company was founded by Freddy Yin Chiang Boey and Subbu S. Venkatraman in 2005 and is headquartered in Mountain View, CA.

Details Hidden

InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2003 and is headquartered in Miami, FL.

Details Hidden

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

Investors
Details Hidden

Consultant & Venture Partner at RiverVest Venture Management LLC

Details Hidden

Managing Director at Lehman Brothers Europe Ltd.

Details Hidden

Life Peer at United Kingdom House of Lords

Suppliers
Bemis Co., Inc. Paper Products

Bemis Co., Inc. engages in the manufacture and sale of packaging for the food, healthcare, and pharmaceutical companies. It operates through the following segments: U.S. Packaging; Latin America Packaging; Rest of the World Packaging; and Corporate. The U.S. Packaging segment manufactures multilayer polymer, blown and cast film structures which are then converted to produce packaging for processed and fresh meat, dairy, liquids, frozen foods, cereals, snacks, cheese, coffee, condiments, candy, pet food, bakery, lawn and garden, tissue, fresh produce, personal care and hygiene, and agribusiness in the United States. The Latin America Packaging segment focuses in the production of multilayer polymer, blown, and cast film structures to produce packaging sold for a variety of food, medical, pharmaceutical, personal care, electronics, and industrial applications in Latin America. The Rest of World Packaging Segment comprises food and non-food packaging-related manufacturing operations located in Europe and Asia-Pacific as well as medical device and pharmaceutical packaging-related manufacturing operations in the U.S., Europe, and Asia. The company was founded by Judson Moss Bemis in 1858 and is headquartered in Neenah, WI.

SurModics, Inc. Medical Products & Equipment | Eden Prairie, MN

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

IXYS LLC Semiconductors | Milpitas, CA

IXYS LLC engages in the design, development, manufacture, and marketing of power semiconductors and mixed-signal integrated circuits. It also offers microcontrollers, green energy products, and radio frequency power and systems. The company was founded by Nathan Zommer in 1983 and is headquartered in Milpitas, CA.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Medtronic Plc Medical Products & Equipment - Dublin, Irl

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Awards & Honors
Rank #359
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #359
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Boston Scientific Corporation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Boston Scientific Corporation's profile does not indicate a business or promotional relationship of any kind between RelSci and Boston Scientific Corporation.